Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CATALIST: Eptifibatide in Acute Ischemic Stroke
NCT00061373Phase 2Completed
- Sponsor
- National Institute of Neurological Disorders and Stroke
- Start
- May 2003
- Primary completion
- Dec 2009
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of eptifibatide in ischemic stroke, sponsored by National Institute of Neurological Disorders and Stroke. Started May 2003; status: completed.
02
Drugs
eptifibatide
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT00061373.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00061373.